InsidersTradesSigma
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
7
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-52.7%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Barer Sol J. Insider active across 3 companies, notably Teva Pharmaceutical Industries Ltd. Cumulatively, 16 filings have been logged. Breakdown: 7 buys · 0 sell. Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Barer Sol J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
21,739 sharesOrdinary SharesSEC:0001193125-26-261715:0
17,158 sharesOrdinary SharesSEC:0000950170-25-083706:0
37,598 sharesOrdinary SharesSEC:0000950170-24-074001:0
28,162 sharesOrdinary SharesSEC:0001209191-23-044769:0
400,000 shares@ €0.376316.9% of flowCommon StockSEC:0001209191-23-021889:0
Canonical exit: 28 Jun 2023 (T+90)
75,000 shares@ €0.46073.9% of flowCommon StockSEC:0001209191-22-057746:0
Canonical exit: 15 Feb 2023 (T+90)
25,791 sharesOrdinary SharesSEC:0001209191-22-037243:0
20,720 shares@ €2.06956.1% of flowCommon StockSEC:0001209191-22-033727:0
Canonical exit: 31 Aug 2022 (T+90)
10,000 shares@ €2.41653.4% of flowCommon StockSEC:0001209191-22-020914:0
Canonical exit: 21 Jun 2022 (T+90)
30,000 shares@ €2.18759.3% of flowCommon StockSEC:0001209191-22-020766:0
Canonical exit: 20 Jun 2022 (T+90)
30,000 shares@ €1.93428.2% of flowCommon StockSEC:0001209191-22-020522:0
Canonical exit: 19 Jun 2022 (T+90)
30,000 shares@ €1.89838.1% of flowCommon StockSEC:0001209191-22-020256:0
Canonical exit: 16 Jun 2022 (T+90)
50,000 shares@ €4.584332.5% of flowCommon StockSEC:0001209191-21-070879:0
22,565 sharesOrdinary SharesSEC:0001209191-21-039367:0
17,565 sharesOrdinary SharesSEC:0001209191-21-038811:0
1 sharesCommon StockSEC:0001615774-16-004023:0
16 of 16 declarations
About Barer Sol J
BARER SOL J is Director at NexImmune, Inc., Teva Pharmaceutical Industries Ltd and InspireMD, Inc. They have 16 filings in total, and across the sampled recent filings the period runs from 2016-01-28 to 2026-06-08, with a transaction type shown as option exercise. The aggregated buy and sell amounts are both EUR 0.
